Inactive Instrument

Amyris Inc Share Price Nasdaq

Equities

US03236M1018

Specialty Chemicals

Sales 2021 342M 27.21B Sales 2022 270M 21.48B Capitalization 556M 44.28B
Net income 2021 -271M -21.58B Net income 2022 -529M -42.12B EV / Sales 2021 4.77 x
Net cash position 2021 38.36M 3.05B Net Debt 2022 917M 73.02B EV / Sales 2022 5.46 x
P/E ratio 2021
-5.55 x
P/E ratio 2022
-0.9 x
Employees -
Yield 2021 *
-
Yield 2022
-
Free-Float 94.16%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 58 15/03/20
Chief Tech/Sci/R&D Officer - 31/12/05
Sales & Marketing - -
Members of the board TitleAgeSince
Director/Board Member 68 31/07/18
Director/Board Member 77 08/08/23
Director/Board Member 72 30/04/06
More insiders
Amyris, Inc. is a synthetic biotechnology company. The component of the Company is derived from marketing and selling Clean Beauty, Personal Care, and Health & Wellness consumer products through its direct-to-consumer e-commerce platforms and a growing network of retail partners. The Company’s sustainable ingredients are sold in bulk to industrial leaders who serve Flavor & Fragrance (F&F), Nutrition, Food & Beverage, and Clean Beauty & Personal Care end markets. The ingredients and consumer products it produces by its Lab-to-Market technology platform. The Company leverages machine learning, robotics, and artificial intelligence, which enables its technology platform to rapidly bring new market at commercial scale. The Lab-to-Market technology platform utilizes optimized and automated molecular biology, analytical, and process development tools combined with machine learning algorithms and statistical models to transform the way microbes metabolize sugars.
More about the company